Jump to content

Isomorphic Labs

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Belt4Orion (talk | contribs) at 17:28, 6 October 2022 (adding dates and city). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Isomorphic Labs is a drug discovery company launched in the United Kingdom in November 2021.

The company was established under London-based AI lab DeepMind,[1] a subsidiary of Alphabet Inc., the parent company of Google.[2] It is led by Demis Hassabis.[2] Isomorphic Labs was incorporated in February 2021 and announced on November 5, 2021.[1]

Isomorphic Labs uses artificial intelligence for drug discovery.[3][4][5]

References

  1. ^ a b Shead, Sam. "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Retrieved August 4, 2022.
  2. ^ a b Coldewey, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch. Retrieved August 23, 2022.
  3. ^ Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Archived from the original on November 5, 2021. Retrieved November 9, 2021.
  4. ^ Crist, Ry (November 4, 2021). "Alphabet launches Isomorphic Labs, an AI-driven drug discovery startup". CNET.
  5. ^ Coldeway, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch.
Stub icon

This Google-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Isomorphic_Labs&oldid=1114471713"